{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:45:42Z","timestamp":1793353542781,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.autrev.2025.103910","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:28:00Z","timestamp":1755041280000},"page":"103910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis"],"prefix":"10.1016","volume":"24","author":[{"given":"Despina","family":"Michailidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniya","family":"Gartshteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca D.","family":"Askanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103910_bb0005","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in growth, metabolism and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.autrev.2025.103910_bb0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4161\/cc.11.2.19022","article-title":"Deconvoluting mTOR biology","volume":"11","author":"Weber","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2025.103910_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0030","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0035","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2025.103910_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BCJ20220325","article-title":"The mTORC2 signaling network: targets and cross-talks","volume":"481","author":"Ragupathi","year":"2024","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2025.103910_bb0045","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.it.2009.02.002","article-title":"The multiple facets of mTOR in immunity","volume":"30","author":"Weichhart","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2567.2009.03125.x","article-title":"mTOR: taking cues from the immune microenvironment","volume":"127","author":"Delgoffe","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103910_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084009","article-title":"SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages","volume":"8","author":"Rocher","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103910_bb0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imm.12126","article-title":"Rapamycin unbalances the polarization of human macrophages to M1","volume":"140","author":"Mercalli","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103910_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/mc.23386","article-title":"Conditional deletion of mTOR discloses its essential role in early B cell development","volume":"61","author":"Zhang","year":"2022","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.autrev.2025.103910_bb0085","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1091\/mbc.e13-07-0405","article-title":"Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac\/Cdc42 activity and the actin cytoskeleton","volume":"24","author":"He","year":"2013","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0095","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","article-title":"Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism","volume":"13","author":"Gingras","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.autrev.2025.103910_bb0100","doi-asserted-by":"crossref","first-page":"26457","DOI":"10.1074\/jbc.272.42.26457","article-title":"Regulation of eIF-4E-PB1 phosphorylation by mTOR","volume":"272","author":"Hara","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2025.103910_bb0105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/onc.2012.606","article-title":"Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program","volume":"33","author":"Chauvin","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.autrev.2025.103910_bb0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2025.103910_bb0115","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.metabol.2007.06.016","article-title":"The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes","volume":"56","author":"Brown","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2025.103910_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2011.07.038","article-title":"Role of S6K1 in regulation of SREBP1c expression in the liver","volume":"412","author":"Li","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2025.103910_bb0125","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1158\/1535-7163.MCT-09-0980","article-title":"Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer","volume":"9","author":"Luyimbazi","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.autrev.2025.103910_bb0130","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1073\/pnas.1103746108","article-title":"The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin resistant transcriptional profile","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2025.103910_bb0135","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/diabetes.53.11.2748","article-title":"Regulation of peroxisome proliferator-activated receptor-\u03b3 activity by mammalian target of rapamycin and amino acids in adipogenesis","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2025.103910_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.12703\/P6-52","article-title":"mTOR and lysosome regulation","volume":"6","author":"Puertollano","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.autrev.2025.103910_bb0145","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00018-014-1565-8","article-title":"Novel roles for the MiTF\/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis","volume":"71","author":"Martina","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2025.103910_bb0150","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The rag GTPases bind raptor and mediate amino acid signalling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103910_bb0155","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2025.103910_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023238","article-title":"Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1","volume":"6","author":"Koyanagi","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103910_bb0165","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 43-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2025.103910_bb0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.aad0489","article-title":"mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle","volume":"351","author":"Ben-Sahra","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103910_bb0175","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1228792","article-title":"Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1","volume":"339","author":"Ben-Sahra","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103910_bb0180","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1074\/jbc.M110.195016","article-title":"Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate","volume":"286","author":"Gan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2025.103910_bb0185","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.molcel.2016.07.015","article-title":"mTORC2 responds to glutamine catabolite levels to modulate the hexosamine biosynthesis enzyme GFAT1","volume":"63","author":"Moloughney","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0190","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41467-018-04849-7","article-title":"A TFEB nuclear export signal integrates amino acid supply and glucose availability","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103910_bb0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molcel.2015.05.030","article-title":"Lysosomal mTORC2\/PHLPP1\/Akt regulate chaperone-mediated autophagy","volume":"59","author":"Arias","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0200","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.1225967","article-title":"Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation","volume":"338","author":"Wang","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103910_bb0205","doi-asserted-by":"crossref","first-page":"12526","DOI":"10.1073\/pnas.1302455110","article-title":"Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology","volume":"110","author":"Betz","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2025.103910_bb0210","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2018.02.012","article-title":"Mitochondria-endoplasmic reticulum contact sites function as immunometabolic hubs that orchestrate the rapid recall response of memory CD8+ T cells","volume":"48","author":"Bantug","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2025.103910_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2013.01.013","article-title":"PI3K\/AKT signaling regulates bioenergetics in immortalized hepatocytes","volume":"60","author":"Li","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.autrev.2025.103910_bb0220","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41556-023-01163-3","article-title":"mTORC2-NDRG1-CDC42 axis couples fasting to mitochondrial fission","volume":"25","author":"Martinez-Lopez","year":"2023","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109939","article-title":"Immunometabolism of systemic lupus erythematosus","volume":"261","author":"Furment","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0230","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","article-title":"mTOR activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus","volume":"35","author":"Lai","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0235","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","article-title":"Advances in systemic lupus erythematosus pathogenesis via mTOR Signaling pathway","volume":"50","author":"He","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103910_bb0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevImmunol.2016017164","article-title":"Metabolic factors that contribute to lupus pathogenesis","volume":"36","author":"Li","year":"2016","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0245","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.clim.2012.07.001","article-title":"Metabolic regulation of organelle homeostasis in lupus T cells","volume":"144","author":"Caza","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-60761-720-4_4","article-title":"Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus","volume":"900","author":"Perl","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0255","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/08916934.2013.834495","article-title":"Metabolic control of the epigenome in systemic lupus erythematosus","volume":"47","author":"Oaks","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103910_bb0260","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg cell differentiation and function by the Interleukin-21-mechanistic target of rapamycin Axis via suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0270","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0275","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/0961203317703497","article-title":"Leptin levels in patients with systemic lupus erythematosus inversely correlate with regulatory T cell frequency","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103910_bb0280","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2014.06.010","article-title":"Leptin modulates autophagy in human CD4+CD25-conventional T cells","volume":"63","author":"Cassano","year":"2014","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.autrev.2025.103910_bb0285","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","article-title":"HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE","volume":"73","author":"Caza","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103910_bb0290","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1038\/s41467-024-46441-2","article-title":"Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation","volume":"15","author":"Huang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103910_bb0295","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s002510050561","article-title":"Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity","volume":"49","author":"Magistrelli","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.autrev.2025.103910_bb0300","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/08830180009055502","article-title":"Lupus susceptibility genes on human chromosome 1","volume":"19","author":"Tsao","year":"2000","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0305","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134010","article-title":"Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1\/RAB4 expression and mTOR activation","volume":"5","author":"Godavarthy","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2025.103910_bb0310","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/MCB.06643-11","article-title":"Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A","volume":"32","author":"Mimura","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0315","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0320","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1\u03b1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of Th17 and T reg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103910_bb0325","doi-asserted-by":"crossref","first-page":"31880","DOI":"10.1074\/jbc.M113.508655","article-title":"cAMP-responsive element modulator \u03b1 (CREM\u03b1) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4\u2212CD8\u2212 T cells in health and disease","volume":"288","author":"Hedrich","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2025.103910_bb0330","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.autrev.2025.103910_bb0335","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-A underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103910_bb0340","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(18)30544-0","article-title":"CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus","volume":"391","author":"Fernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103910_bb0345","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1172\/JCI30398","article-title":"Shared signaling networks active in b cells isolated from genetically distinct mouse models of lupus","volume":"117","author":"Wu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103910_bb0350","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.1601908","article-title":"Metabolic reprogramming commits differentiation of human CD27+ IgD+ b cells to plasmablasts or CD27\u2212IgD\u2212cells","volume":"199","author":"Torigoe","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1155421","article-title":"B cell activation via immunometabolism in systemic lupus erythematosus","volume":"14","author":"Iwata","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0360","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1172\/JCI86504","article-title":"mTOR has distinct functions in generating versus sustaining humoral immunity","volume":"126","author":"Jones","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103910_bb0365","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1074\/jbc.M116.713842","article-title":"Epigenetic regulation of the blimp-1 gene (Prdm1) in b cells involves Bach2 and histone deacetylase 3","volume":"291","author":"Tanaka","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2025.103910_bb0370","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.165.9.5338","article-title":"Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c","volume":"165","author":"Siebling","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0375","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.kint.2023.03.030","article-title":"Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways","volume":"104","author":"Yoo","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2025.103910_bb0380","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1093\/rheumatology\/keac037","article-title":"Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis","volume":"61","author":"Mao","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103910_bb0385","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2025.103910_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.636188","article-title":"HMGB1 activates myeloid dendritic cells by up regulating mTOR pathway in systemic lupus erythematosus","volume":"8","author":"Song","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2025.103910_bb0395","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10295-016-1834-7","article-title":"An overview of rapamycin: from discovery to future perspectives","volume":"44","author":"Yoo","year":"2017","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.autrev.2025.103910_bb0400","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+CD4-CD8-double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0405","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4049\/jimmunol.0803600","article-title":"Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation","volume":"182","author":"Fernandez","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0410","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfn216","article-title":"Rapamycin attenuates the severity of established nephritis in lupus-prone NZB\/W F1 mice","volume":"23","author":"Lui","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2025.103910_bb0415","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-016-0989-y","article-title":"CD163+M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis","volume":"18","author":"Olmes","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2025.103910_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111289","article-title":"Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function","volume":"137","author":"Song","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2025.103910_bb0425","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0430","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ndt\/gfq496","article-title":"The PI3K\/Akt\/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin","volume":"26","author":"Stylianou","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2025.103910_bb0435","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/abbs\/gmy088","article-title":"mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.autrev.2025.103910_bb0440","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1400044","article-title":"Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis","volume":"193","author":"Kshirsagar","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1446836","article-title":"Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus","volume":"15","author":"Kim","year":"2024","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2025.103910_bb0450","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103910_bb0455","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase \u00bd trial","volume":"39","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103910_bb0460","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/annrheumdis-2019-215039","article-title":"Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2025.103910_bb0465","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3899\/jrheum.180507","article-title":"Longterm data on sirolimus treatment in patients with lupus nephritis","volume":"45","author":"Yap","year":"2025","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0470","article-title":"Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis","volume":"12","author":"Peng","year":"2020","journal-title":"Ther Adv Muscoloskeletal Dis"},{"key":"10.1016\/j.autrev.2025.103910_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108781","article-title":"Improvement of renal and non-renal SLE outcome measures on sirolimus therapy. A 21-year follow-up study of 73 patients","volume":"229","author":"Piranavan","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0480","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: a potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2025.103910_bb0485","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1440-1797.2012.01646.x","article-title":"Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience","volume":"17","author":"Yap","year":"2012","journal-title":"Nephrology (Caltron)"},{"key":"10.1016\/j.autrev.2025.103910_bb0490","article-title":"Principles behind SLE treatment with N-acetylcysteine","volume":"4","author":"Nasr","year":"2022","journal-title":"Immunometabolism (Cobham)"},{"key":"10.1016\/j.autrev.2025.103910_bb0495","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103910_bb0500","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/annrheumdis-2019-216145","article-title":"Clinical symptoms and associated vascular imaging findings in Takayasu\u2019s arteritis compared to giant cell arteritis","volume":"79","author":"Michailidou","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103910_bb0505","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11926-020-00948-x","article-title":"Pathogenesis of Giant cell arteritis and Takayasu arteritis-similarities and differences","volume":"22","author":"Watanabe","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2025.103910_bb0510","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.coi.2008.03.004","article-title":"Notch signaling in CD4 and CD8 T cell development","volume":"20","author":"Laky","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3322","article-title":"The microvascular niche instructs T cells in large vessel Vasculitis via the VEGF-Jagged1-Notch pathway","volume":"9","author":"Wen","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2025.103910_bb0520","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6604921","article-title":"The VEGF pathway and the AKT\/mTOR\/p70S6KI signalling pathway in human epithelial ovarian cancer","volume":"100","author":"Trinh","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.autrev.2025.103910_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587089","article-title":"Cellular Signaling pathways in medium and large vessel Vasculitis","volume":"11","author":"Watanabe","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0530","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/antiox10060885","article-title":"An insight into giant cell arteritis pathogenesis: evidence for oxidative stress and SIRT1 downregulation","volume":"10","author":"Ianni","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.autrev.2025.103910_bb0535","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2019.01.049","article-title":"CD28 signaling controls metabolic fitness of pathogenic T cells in medium and large vessel vasculitis","volume":"73","author":"Zhang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2025.103910_bb0540","first-page":"E970","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2025.103910_bb0545","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/art.42103","article-title":"Notch1 licenses mTOR hyperactivity and drives vascular inflammation in patients with Takayasu\u2019s arteritis","volume":"74","author":"Jiang","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0550","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2018.07.013","article-title":"mTOR pathway activation in large vessel Vasculitis","volume":"94","author":"Maciejewski-Duval","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103910_bb0555","first-page":"33","article-title":"Silent arterial inflammation during the apparent remission state of Takayasu\u2019s arteritis. What do cytokines tell us?","volume":"36","author":"Savioli","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0560","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/art.42103","article-title":"Critical role of Notch-1 in mechanistic target of rapamycin hyperactivity and vascular inflammation in patients with Takayasu arteritis","volume":"74","author":"Jiang","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0565","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/key017","article-title":"mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G","volume":"57","author":"Hadjadj","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103910_bb0570","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.autrev.2016.12.012","article-title":"Anti-endothelial cell antibodies in vasculitis: a systematic review","volume":"16","author":"Legendre","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103910_bb0575","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2249.2003.02282.x","article-title":"Anti-annexin V antibodies in Takayasu\u2019s arteritis: prevalence and relationship with disease activity","volume":"134","author":"Tripathy","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0580","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/s41467-020-15088-0","article-title":"Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis","volume":"11","author":"Mutoh","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103910_bb0585","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2011.08.001","article-title":"Pathogenesis of Takayasu\u2019s arteritis: a 2011 update","volume":"11","author":"Arnaud","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103910_bb0590","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/Akt\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.autrev.2025.103910_bb0595","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1172\/JCI28984","article-title":"PDGRs are critical for PI3K\/Akt activation and negatively regulated by mTOR","volume":"117","author":"Zhang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103910_bb0600","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-022-00911-1","article-title":"Age as a risk factor in vasculitis","volume":"44","author":"Gloor","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2025.103910_bb0605","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1038\/s44319-024-00251-1","article-title":"mTOR signaling controls the formation of smooth muscle cell-derived luminal myofibroblasts during vasculitis","volume":"25","author":"Stock","year":"2024","journal-title":"EMBO Rep"},{"key":"10.1016\/j.autrev.2025.103910_bb0610","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.42340","article-title":"Mechanistic target of rapamycin inhibition prevents coronary artery remodeling in a murine model of Kawasaki disease","volume":"75","author":"Stock","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1420602","article-title":"Ferulic acid suppresses the inflammation and apoptosis in Kawasaki disease through activating the AMPK\/mTOR\/NF-\u03baB pathway","volume":"15","author":"Wu","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2025.103910_bb0620","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13075-022-02849-z","article-title":"Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis","volume":"24","author":"Michailidou","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2025.103910_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1227369","article-title":"Activity of granulomatosis with polyangiitis and its correlation with mTOR phosphoproteomics in neutrophils","volume":"14","author":"Surmiak","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0630","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/0886022X.2019.1667829","article-title":"The role of mammalian target of rapamycin pathway in the pathogenesis of pauci-immune glomerulonephritis","volume":"41","author":"Soypacaci","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.autrev.2025.103910_bb0635","doi-asserted-by":"crossref","first-page":"F1023","DOI":"10.1152\/ajprenal.00018.2014","article-title":"Mammalian target of rapamycin complex 1 activation in podocyte promotes cellular crescent formation","volume":"307","author":"Mao","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.autrev.2025.103910_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.147101","article-title":"MTOR gene polymorphism may be associated with microscopic polyangiitis susceptibility in a Guangxi population of China","volume":"854","author":"Lan","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2025.103910_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.789740","article-title":"Oxidative stress promotes instability of regulatory T cells in antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"12","author":"Shimojima","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0650","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.41084","article-title":"Targeting mechanistic target of rapamycin complex 1 restricts proinflammatory T cell differentiation and ameliorates Takayasu arteritis","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0655","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/1753425916668981","article-title":"Autophagy is induced by anti-neutrophil cytoplasmic abs and promotes neutrophil extracellular traps formation","volume":"22","author":"Sha","year":"2016","journal-title":"Innate Immun"},{"key":"10.1016\/j.autrev.2025.103910_bb0660","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3899\/jrheum.080664","article-title":"Limited utility of rapamycin in severe, refractory Wegener\u2019s granulomatosis","volume":"36","author":"Koening","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0665","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1080\/03009742.2020.1777324","article-title":"Sirolimus use in patients with subglottic stenosis in the context of granulomatosis with polyangiitis (GPA), suspected GPA, and immunoglobulin G4-related disease","volume":"50","author":"Poo","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0670","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1749-6632.1993.tb35852.x","article-title":"Rapamycin: in vitro profile of a new immunosuppressive macrolide","volume":"685","author":"Sehgal","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2025.103910_bb0675","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0680","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3390\/molecules27165295","article-title":"Overview of research into mTOR inhibitors","volume":"27","author":"Mao","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.autrev.2025.103910_bb0685","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acsmedchemlett.6b00149","article-title":"CZ415, a highly selective mTOR inhibitor showing in vivo efficacy in a collagen induced arthritis model","volume":"7","author":"Cansfield","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.autrev.2025.103910_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109274","article-title":"Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis","volume":"249","author":"Michailidou","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619705","article-title":"Role of neutrophils in systemic Vasculitides","volume":"11","author":"Michailidou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0700","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2011.132","article-title":"Neutrophils in the pathogenesis and manifestations of SLE","volume":"7","author":"Kaplan","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0705","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0014-5793(03)00828-7","article-title":"Rapamycin inhibits GM-CSF-induced neutrophil migration","volume":"550","author":"Gomez-Cambronero","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2025.103910_bb0710","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1083\/jcb.201503066","article-title":"mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis","volume":"210","author":"Bao","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0715","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2021-220873","article-title":"Blocking GM-CSF receptor \u03b1 with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis","volume":"81","author":"Corbera-Bellalta","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103910_bb0720","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2249.2000.01205.x","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro","volume":"120","author":"Hellmich","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2025.103910_bb0725","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/37.8.901","article-title":"Leukocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener\u2019s granulomatosis","volume":"37","author":"Muller Kobold","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103910_bb0730","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1165\/rcmb.2008-0290OC","article-title":"Participation of mammalian target of rapamycin complex 1 in toll-like receptor 2- and 4- induced neutrophil activation and acute lung injury","volume":"41","author":"Lorne","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2025.103910_bb0735","doi-asserted-by":"crossref","first-page":"F1283","DOI":"10.1152\/ajprenal.00040.2018","article-title":"Intrarenal toll-like receptor 4 and toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"315","author":"O\u2019Sullivan","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.autrev.2025.103910_bb0740","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB Signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103910_bb0745","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1158\/0008-5472.CAN-22-0602","article-title":"Challenges and emerging opportunities for targeting mTOR in cancer","volume":"82","author":"Wood","year":"2022","journal-title":"Cancer Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:54:58Z","timestamp":1763769298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":149,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1568997225001715"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103910","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103910"}}